Gara Jalqabaatti › Dhukkubbee Onkoloo Interstishiyali › South Carolina
Qorannoo klinikaalii Dhukkubbee Onkoloo Interstishiyali South Carolina keessatti
Qorannoo 14 Dhukkubbee Onkoloo Interstishiyali f South Carolina keessatti hirmaatuu jiru.
Magaalota South Carolina keessatti
Takkalaa qorannoo (Ingiliffa)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Lowcountry Lung and Critical Care, Charleston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Medical University of South Carolina, Charleston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- MUSC, Charleston
- Velocity Clinical Research, Spartanburg
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT05798923SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
- Medical University of South Carolina, Charleston
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07269262A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Medical University of South Carolina, Charleston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Medical University of South Carolina, Charleston
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06911632A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Charleston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- AnMed Health, Anderson
- Medical University of South Carolina, Charleston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Medical University of South Carolina (MUSC), Charleston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06195072Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Medical University of South Carolina, Charleston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 21 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT01915511Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Medical University of South Carolina-Nexus, Charleston
- Prisma Health Pulmonology-Richland, Columbia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT05943535An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Medical University of South Carolina, Charleston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT06129240Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Bogan Sleep Consultants, LLC, Columbia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 12-Sad-2025 · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Charleston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Cam-2025 · NCT05892614Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.